Form 4 for SABS SAB Biotherapeutics, Inc.
Accepted 2022-09-14 00:00:00 ET · period of report 2022-09-13 · accession 0001209191-22-049950 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-14 | 2022-09-13 | SABS | HAMILTON CHRISTINE E | Dir, 10% | P - Purchase | $0.73 | +10.0K | 4.99M | +0.2% | +$7,300 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-13 | P | A | 10,000 | $0.73 | 4,993,090 | D | — | — | (F1) Does not include: (i) 25,000 shares of common stock held by Christensen Investments, LLC, (ii) 2,909,022 shares of common stock held by the reporting persons spouse, Dr. Edward Hamilton, and (iii) 91,261 shares of common stock which the reporting person co-owns with Dr. Hamilton, all of which the reporting person may be deemed to beneficially own. The reporting person disclaims any beneficial ownership of these shares of common stock other than to the extent of any pecuniary interests the reporting person may have therein. |